Long-term subcutaneous treprostinil (Remodulin) therapy for severe pulmonary arterial hypertension

被引：0
|
作者：
Skoro-Sajer, N.
Bonderman, D.
Harja, E.
Jakowitsch, J.
Maurer, G.
Kneussl, M.
Lang, I. M.
机构：
[1] Vienna Gen Hosp, Dept Cardiol, Vienna, Austria
[2] Wilhelminenspital Stadt Wien, Vienna, Austria
来源：
EUROPEAN HEART JOURNAL | 2005年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P595
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [1] Long-term continuous subcutaneous treprostinil therapy for pulmonary arterial hypertension
    Skoro-Sajer, N
    Harja, E
    Bonderman, D
    Rezaie-Majd, S
    Machherndl, S
    Kneussl, M
    Lang, MI
    EUROPEAN HEART JOURNAL, 2003, 24 : 483 - 483
  • [2] Treprostinil (remodulin) for pulmonary arterial hypertension
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2002, 44 (1139): : 80 - 82
  • [3] Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension
    Lang, Irene
    Gomez-Sanchez, Miguel
    Kneussl, Meinhard
    Naeije, Robert
    Escribano, Pilar
    Skoro-Sajer, Nika
    Vachiery, Jean-Luc
    CHEST, 2006, 129 (06) : 1636 - 1643
  • [4] Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil
    Barst, R. J.
    Galie, N.
    Naeije, R.
    Simonneau, G.
    Jeffs, R.
    Arneson, C.
    Rubin, L. J.
    EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (06) : 1195 - 1203
  • [5] Continuous subcutaneous infusion of Remodulin™, a prostacyclin analogue, in patients with pulmonary arterial hypertension:: Long-term outcome
    McLaughlin, V
    Sitbon, O
    Sigman, J
    Blackburn, S
    CIRCULATION, 2001, 104 (17) : 250 - 250
  • [6] Long-term safety and outcome of subcutaneous and intravenous treprostinil in patients with severe chronic pulmonary hypertension
    Harutyunova, Satenik
    Benkamin, Nicola
    Eichstaedt, Christina
    Marra, Alberto Maria
    Xanthouli, Panagiota
    Egenlauf, Benjamin
    Gruenig, Ekkehard
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [7] Combination Therapy For Pulmonary Arterial Hypertension With Oral Treprostinil: Long-Term Follow Up
    Ruggiero, R. M.
    Bartolome, S.
    Chin, K. M.
    Torres, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [8] Long-Term Safety, Outcome, and Clinical Effects of Subcutaneous and Intravenous Treprostinil Treatment in Patients with Severe Chronic Pulmonary Arterial Hypertension
    Harutyunova, Satenik
    Benjamin, Nicola
    Eichstaedt, Christina
    Marra, Alberto M. M.
    Xanthouli, Panagiota
    Nagel, Christian
    Gruenig, Ekkehard
    Egenlauf, Benjamin
    RESPIRATION, 2023, 102 (08) : 579 - 590
  • [9] USE OF SUBCUTANEOUS TREPROSTINIL IN PEDIATRIC PULMONARY ARTERIAL HYPERTENSION - BRIDGE-TO-TRANSPLANT OR LONG-TERM TREATMENT?
    Ablonczy, L.
    PEDIATRIC TRANSPLANTATION, 2017, 21 : 11 - 11
  • [10] Long-term safety and outcome of subcutaneous and intravenous treprostinil treatment in patients with severe chronic pulmonary hypertension
    Harutyunova, S.
    Benjamin, N.
    Eichstaedt, C.
    Marra, A. M.
    Xanthouli, P.
    Egenlauf, B.
    Gruenig, E.
    PNEUMOLOGIE, 2020, 74 : S125 - S125
12345